Description

ARTVIGIL 250 MG

Indications

ARTVIGIL 250 MG is primarily indicated for the treatment of narcolepsy, a chronic sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks. It is also used to manage shift work sleep disorder (SWSD), which affects individuals who work non-traditional hours and experience sleep disruptions. Additionally, ARTVIGIL may be prescribed as an adjunct treatment for attention-deficit hyperactivity disorder (ADHD) in adults, enhancing focus and reducing impulsivity.

Mechanism of Action

The active ingredient in ARTVIGIL is modafinil, a wakefulness-promoting agent. Although the exact mechanism of action is not fully understood, it is believed to work by altering neurotransmitter levels in the brain. Modafinil primarily affects the hypothalamus and increases the release of dopamine, a neurotransmitter associated with pleasure and reward. It may also enhance the activity of norepinephrine and serotonin, contributing to increased alertness and cognitive function. Unlike traditional stimulants, modafinil has a lower potential for abuse and dependency.

Pharmacological Properties

ARTVIGIL is classified as a eugeroic agent, which means it promotes wakefulness without the jitteriness typically associated with stimulants. The pharmacokinetics of modafinil indicate that it has a rapid absorption profile, with peak plasma concentrations occurring approximately 2 to 4 hours after oral administration. The half-life of modafinil ranges from 12 to 15 hours, allowing for once-daily dosing in most cases. It is primarily metabolized in the liver via the cytochrome P450 enzyme system, particularly CYP3A4, leading to the formation of several inactive metabolites.

Contraindications

ARTVIGIL 250 MG is contraindicated in individuals with a known hypersensitivity to modafinil or any of the excipients in the formulation. It should not be used in patients with a history of severe skin reactions, such as Stevens-Johnson syndrome or toxic epidermal necrolysis, associated with modafinil. Additionally, caution is advised in patients with a history of cardiovascular disorders, as modafinil may increase blood pressure and heart rate.

Side Effects

Common side effects associated with ARTVIGIL include headache, nausea, dizziness, and insomnia. Some patients may experience anxiety, nervousness, or gastrointestinal disturbances. Rare but serious side effects may include severe allergic reactions, psychiatric symptoms such as hallucinations or mania, and cardiovascular events. Patients should be monitored for any unusual changes in behavior or mood, and any serious side effects should be reported to a healthcare provider immediately.

Dosage and Administration

The recommended dosage of ARTVIGIL for adults is typically 200 mg to 400 mg once daily, taken in the morning for narcolepsy or SWSD. For patients with ADHD, the dosage may vary based on individual response and tolerance, but it generally starts at 250 mg and can be adjusted as needed. It is important to follow the prescribing physician’s instructions regarding dosage and to avoid exceeding the recommended daily limit. ARTVIGIL can be taken with or without food, but it is advisable to maintain a consistent routine to optimize its effects.

Interactions

Modafinil has the potential to interact with various medications due to its effects on the cytochrome P450 enzyme system. It may reduce the effectiveness of oral contraceptives and other medications metabolized by CYP3A4, such as certain antiepileptics, anticoagulants, and antidepressants. Conversely, some drugs may increase the metabolism of modafinil, potentially reducing its efficacy. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Before initiating treatment with ARTVIGIL, a thorough medical history should be taken to assess for any pre-existing conditions, particularly cardiovascular issues, liver impairment, or a history of psychiatric disorders. Regular monitoring of blood pressure and heart rate is recommended during treatment. Patients should be advised to avoid alcohol and other central nervous system depressants while taking ARTVIGIL, as these can exacerbate side effects. Caution is also warranted in elderly patients, who may be more susceptible to adverse effects.

Clinical Studies

Numerous clinical studies have evaluated the efficacy and safety of ARTVIGIL in various populations. In a randomized, double-blind, placebo-controlled trial involving patients with narcolepsy, ARTVIGIL demonstrated significant improvements in wakefulness and reduced daytime sleepiness compared to placebo. Another study focusing on shift work sleep disorder found that modafinil significantly improved alertness and performance during night shifts. Long-term studies have also indicated that ARTVIGIL is generally well-tolerated, with a low incidence of serious adverse effects, supporting its use as a first-line treatment for sleep disorders.

Conclusion

ARTVIGIL 250 MG, containing modafinil, is an effective medication for the treatment of narcolepsy, shift work sleep disorder, and as an adjunct treatment for ADHD in adults. Its unique mechanism of action and favorable side effect profile make it a valuable option for patients seeking to enhance wakefulness and cognitive function. As with any medication, it is essential for patients to use ARTVIGIL responsibly and under the guidance of a healthcare professional.